← Evidence map

ArticleThe New England journal of medicine2017

A Highly Durable RNAi Therapeutic Inhibitor of PCSK9.

Kevin Fitzgerald et al.PubMed ↗Publisher ↗

No numbers read from the abstract.

18 papers cite it

2017
2018
2019
2020
2021
2022
2023
2024
2025
2026
this papertrialcites it
Full record →Abstract, authors, funding and every citing paper · PMID 28467871